Clover Health is offering its AI assistant to all Medicare Advantage payers and providers

 Clover Health is offering its AI assistant to all Medicare Advantage payers and providers

Photo: MoMo Productions/Getty Images

Clover Health has announced that its clinical decision support tool, Clover Assistant, is now available to payers outside of Clover’s Medicare Advantage plans and also to providers.

The tool, branded as Counterpart Assistant, is a strategic move with Counterpart Health, a subsidiary of MA insurer Clover Health. It gives Clover a new pathway to growth leveraging its existing technology assets.

Clover Assistant is designed to aggregate patient data to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease.

The move aims to extend the benefits of data-driven technology, personalized care to a wider audience, enabling enhanced patient outcomes and reduced healthcare costs across the nation, Clover said.


Counterpart’s proprietary technology platform is now live with its first clinician users in external software-as-a-service (SaaS) and value-based arrangements. It supports clinicians in a range of practices, from large integrated health systems to small, ACO-affiliated community practices. 

Counterpart Assistant employs a hybrid SaaS and shared-savings model, with options for full capitation. This ensures flexibility and alignment of financial incentives with improved health outcomes, Clover said.

Clinicians using Counterpart Assistant see over 1,000 basis point differential in Medical Cost Ratios, Clover said.

The model delivers value-based success using data, artificial intelligence and machine learning to enhance the data and suggestions available to clinicians to improve patient care.


Leveraging Clover’s experience with its own MA plan, Counterpart Health provides full implementation support, including training, integration assistance and ongoing technical support. CA’s cloud-native architecture ensures scalability.

Clover has released retrospective data analyses exploring the significant association between CA use and early diagnosis of diabetes and chronic kidney disease as well as improved medication adherence.

Clover Health is a physician enablement technology company founded in 2014.


“We are incredibly proud of CA and the clinical improvements it brings to value-based care including through its association with the improved identification and management of chronic disease,” said Andrew Toy, CEO of Clover Health. “At Clover, we measure the progress of our mission and the progress of our business by the same metric – the number of lives managed by primary care physicians using our CA technology. By making CA available to be used to manage lives that are in other Medicare Advantage plans, we are taking a significant step towards our mission of improving healthcare for all. The usage of CA remains consistent – a patient is a patient – so we feel this is a great way to grow the number of lives under CA management quickly.”


Email the writer:

Source link

Fallon Wolken

Related post

Leave a Reply

Your email address will not be published. Required fields are marked *